Stock analysts at Deutsche Bank Aktiengesellschaft – 3 stars initiated coverage on shares of Moderna (NASDAQ:MRNA) in a report issued on Friday. The brokerage set a Sell rating on the Medical stock.
View More Coverage Initiated by Deutsche Bank Aktiengesellschaft – 3 stars for Moderna (NASDAQ:MRNA)
Moderna} stock has undergone multiple analysts rating changes in the recent past. Moderna Upgraded by Piper Sandler on 10/15/2021. In a note to investors, the firm issued a new rating of Overweight. The analysts previously had rating of Neutral.
View More Moderna (MRNA) Upgraded by Piper Sandler to Overweight
Earnings results for Moderna , Analyst Opinion on Moderna , Earnings and Valuation of (NASDAQ:MRNA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,
View More Nothing seems to bother Moderna (NASDAQ:MRNA)
Earnings results for Moderna , Analyst Opinion on Moderna , Earnings and Valuation of (NASDAQ:MRNA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,
View More Analyst Valuation and EPS Growth for Moderna (NASDAQ:MRNA)
Earnings results for Moderna , Analyst Opinion on Moderna , Earnings and Valuation of (NASDAQ:MRNA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,
View More Does Earnings Surprise History Hold Any Clue for Moderna (NASDAQ:MRNA)Earnings results for Moderna , Analyst Opinion on Moderna , Earnings and Valuation of (NASDAQ:MRNA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,
View More Analysts Estimate Report : What to Look Out for Moderna (NASDAQ:MRNA)
Earnings results for Moderna , Analyst Opinion on Moderna , Earnings and Valuation of (NYSE:EXTN), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,
View More Does Earnings Surprise History Hold Any Clue for Moderna (NYSE:EXTN)
Earnings results for Moderna , Analyst Opinion on Moderna , Earnings and Valuation of (NASDAQ:MRNA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,
View More Factors Likely to Have Influenced Earnings Results Moderna (NASDAQ:MRNA)